In a previous
publication we described the study design extensively.13 The effects of the physical activity stimulation program on social participation, quality of ISRIB chemical structure life and self-perception will be reported in a separate paper. Participants were randomised 1:1 to the experimental or control intervention, with stratification by Gross Motor Function Classification System (GMFCS) level I versus level II/III. The GMFCS level I is walking without limitations, level II is walking with limitations and level III is walking with a hand-held mobility device.14 Sealed envelopes were used to conceal group allocation. Participants were informed of group allocation following the baseline assessments. The intervention group followed a 6-month physical activity stimulation program, involving a lifestyle intervention and 4 months of fitness training. The control group continued their usual paediatric physiotherapy.
Outcomes were assessed in the hospital: at baseline; at 4 months (ie, at the end of fitness training, when only walking capacity, functional strength and fitness were assessed); at 6 months (that is, at the end of the intervention); and at 12 months. The assessor (AB) was blinded to group allocation throughout the study. The parents’ attitudes towards sport were only assessed at baseline and 12 months. Children with spastic cerebral palsy, aged 7–13 years who could walk were recruited via paediatric physiotherapy practices and special schools for children with disabilities. Inclusion criteria were: PLX-4720 order classification in GMFCS level I–III, understanding of the Dutch language and fulfilling at least one of the following criteria as determined
in a telephone interview: less active than the international physical activity norm of less than 1 hour daily at >5 metabolic equivalents (METs), which is moderate or vigorous intensity;15 no regular participation in sports or (physiotherapeutic) fitness program (ie, less than three times a week for at least 20 minutes); and experience of problems related Linifanib (ABT-869) to mobility in daily life or sports. Exclusion criteria were: surgery in the previous 6 months, botulinum toxin treatment or serial casting in the previous 3 months (or planned), unstable seizures, contra-indications for physical training, severe behavioural problems, severe intellectual disability and a predominantly dyskinetic or ataxic movement disorder. The intervention group followed the physical activity stimulation program, which involved a lifestyle intervention and fitness training followed by usual physiotherapy. The control group undertook only usual physiotherapy. The components of the interventions are presented in Figure 1 and described in more detail elsewhere.